Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Pivotal Therapeutics Inc.
DescriptionLong acting formulation of Omega-3 polyunsaturated fatty acids
Molecular Target Nitric oxide (NO)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationAtherosclerosis
Indication DetailsStabilize vulnerable plaque in patients undergoing carotid endarterectomy
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today